Skip to content
★ Sign in to follow
PP

Phillip Pang

Executive
Chief Medical Officer
Total declarations
115
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (64 ops.)
€9.6M

Latest filing published 26 Feb 2024 for Vir Biotechnology, Inc., €135k.

Filing timeline

BuySale
Phillip Pang

Insider track record

Disclosed buys
0
Disclosed sells
64

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Phillip Pang: trading record in brief

Phillip Pang (senior executive) discloses dealings in Vir Biotechnology, Inc. to SEC (Form 4). The record holds 115 filings, for trades running from 17 April 2020 to 22 February 2024.

Every open-market trade on record is a sale: 64 sales worth €9.6M. Outside the open market, there are 6 share grants and 44 option exercises. In 2024 alone, the filings show no purchases and 2 sales.

On 26 February 2024 came the latest disclosure, an open-market sale for €135k in Vir Biotechnology, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Phillip Pang

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations30 total

25 of 30 declarations